Abstract 6420: Harnessing immune responses in prostate MMRd tumors treated with immune checkpoint blockade
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-6420
Abstract: There is increasing evidence correlating tumor mutational burden with response to immunotherapy in many different types of cancer. Some tumors show high microsatellite instability (MSI-H) as a consequence of the loss of function of mismatch… read more here.
Keywords: immune checkpoint; immune responses; mmrd tumors; tumor ... See more keywords
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.982790
Abstract: Background Anti-PD-(L)1 treatment is indicated for patients with mismatch repair-deficient (MMRD) tumors, regardless of tumor origin. However, the response rate is highly heterogeneous across MMRD tumors. The objective of the study is to find a… read more here.
Keywords: mmrd tumors; volume; tumor volume; total tumor ... See more keywords